PPPaveena Pithuksurachai

Paveena Pithuksurachai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paveena Pithuksurachai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Visual Parathyroid Identification in Thyroidectomy: A Decision Curve Analysis of Gland Preservation

    by Paveena Pithuksurachai, Warut Pongsapich, Noppadon Triprateepsilp, Cheerasook Chongkolwatana, Narin Ratanaprasert, Sanyaluck Wattanachalermyos

    Objective: To evaluate the clinical utility and net benefit of intraoperative visual identification for parathyroid preservation during thyroidectomy using decision curve analysis (DCA). Methods: Suspected parathyroid tissues ( n = 50) were identified intraoperatively by junior staff and residents and photographed for independent consensus review by three expert otolaryngologists. Fine‐needle aspiration parathyroid hormone washout (electrochemiluminescence immunoassay; ≥ 100 pg/mL) served as the surrogate biochemical reference standard. Diagnostic performance was assessed using contingency tables, logistic regression, receiver operating characteristic analysis, and DCA. Results: Expert visual identification achieved 84.0% sensitivity, 44.0% specificity, and 64.0% accuracy. Positive predictive values were 60.0% for experts, 51.5% for junior staff, and 47.1% for residents ( p = 0.632). Logistic regression yielded odds ratios of 1.69 for experts ( p = 0.380) and 1.20 for junior staff ( p = 0.765); model AUC was 0.56. DCA showed greater net benefit than “Treat All” and “Treat None” strategies at a clinically relevant threshold probability of 27%. Conclusion: Visual identification demonstrates limited diagnostic accuracy that did not differ significantly across experience levels, although this comparison is constrained by differing assessment conditions. The low specificity underscores the need for objective adjunctive confirmation and supports evaluating biochemical and optical adjuncts in future prospective studies. Level of Evidence: 2.

  • Open Access

    Pain Outcomes and Predictors in Transoral Vestibular Thyroidectomy

    by Sawita Kanavitoon, Nutnicha Farungsang, Suratsawadee Wangnamthip, Prachya Maneeprasopchoke, Paveena Pithuksurachai, Thipthiwa Pocapan, Saowapark Chumpathong

  • Open Access

    Determinants of patient preference for TOETVA versus open thyroidectomy: Patient-reported outcome measures

    by Aimpat Aungsusiripong, Warut Pongsapich, Paveena Pithuksurachai, Prachya Maneeprasopchoke

  • A Simple Technique for Probe‐Based NIRAF ‐Guided Parathyroid Identification in TOETVA

    by Prachya Maneeprasopchoke, Aimpat Aungsusiripong, Paveena Pithuksurachai, Angkoon Anuwong, Marika D. Russell, Amr H. Abdelhamid Ahmed, Gregory W. Randolph

    We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.


  • A Novel Connector for Intraoperative Nerve Monitoring Probes in Endoscopic Thyroidectomy: Comparative Efficacy and Preclinical Evaluation in a Porcine Model

    by Parnwad Chairat, Paveena Pithuksurachai, Cheerasook Chongkolwatana, Pongsakorn Wechakarn, Yada Akkhawattanangkul, Kewvaree Hommuang, Phingphol Charoonrut, Tanyanan Jamikorn, Angkoon Anuwong, Che‐Wei Wu, et al.

    Background: This study aimed to develop a connector that adapts standard endoscopic instruments into functional nerve stimulator probes. Methods: The connector underwent engineering validation in a laboratory and preclinical testing using a porcine model. A handheld standard stimulator probe served as the control. The experimental group consisted of a long monopolar probe and two connector‐adapted probes. Recurrent laryngeal nerve (RLN) and vagus nerves were stimulated to compare the efficacy and safety of the adapted probes with the standard probe. Results: The connector, when coupled to endoscopic instruments, did not show a statistically significant difference in electromyographic (EMG) amplitude at 1 mA stimulation compared with the standard probe. Safety analysis showed no significant hemodynamic effects. Conclusion: This proof‐of‐concept study demonstrates that the developed connector, when paired with endoscopic instruments, enables reliable nerve identification and preservation during endoscopic thyroid surgery, with favorable efficacy and safety profiles.

  • Open Access

    The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation

    by Tauangtham Anekpuritanang, Maythad Uataya, Apichaya Claimon, Natthawadee Laokulrath, Warut Pongsapich, Paveena Pithuksurachai

    Objective: To study the association between radioiodine refractory papillary thyroid carcinoma, sodium/iodide symporter (NIS) expression, and the BRAFV600E mutation. Methods: A study was conducted on 30 radioiodine refractory papillary thyroid carcinoma patients and 30 radioiodine-avid papillary thyroid carcinoma patients. The expressions of sodium/iodide symporter and BRAFV600E mutated protein were determined by immunohistochemistry using formalin-fixed, paraffin-embedded tissue. Results: The mutated BRAFV600E protein was identified in 26 radioiodine refractory papillary thyroid carcinoma subjects (86.7%) and 22 radioiodine-avid papillary thyroid carcinoma subjects (73.3%), with no significant difference between the 2 groups (P = 0.3). Sodium/iodide symporter expression was detected in 4 of 30 cases (13.3%) from the radioiodine-avid papillary thyroid carcinoma group but was negative for all radioiodine refractory cases. There was no association between sodium/iodide symporter expression and radioiodine refractory papillary thyroid carcinoma (P = 0.11). Cases with positive NIS expression were likely negative for BRAFV600E mutation (3/4; P = 0.02). Conclusion: Papillary thyroid carcinomas with BRAFV600E mutation were more likely to be negative for NIS expression. BRAFV600E mutation and NIS expressions cannot be used to predict radioiodine sensitivity.